Over recent decades, advancements in diabetes management, including improved insulin therapies, continuous glucose monitoring, and multidisciplinary care approaches, have contributed to extended life expectancy in individuals with T1D (11) and type 2 diabetes (T2D) (12). This evidence concerns the gene INS and type 2 diabetes mellitus.